T cells may contribute to histological progression of premalignancy in a murine model of lung squamous cell carcinoma

Learning Objectives:

1. Developing and characterizing model systems for lung squamous cell carcinoma (LSCC) is key to understanding LSCC preinvasive disease and tumorigenesis. 

2.  The local immune microenvironment may contribute to the progression of premalignancy in early LSCC. 

3. Understanding the contribution of the immune system to LSCC tumorigenesis may allow for development of immunomodulatory cancer intervention strategies. 

 

Faculty Disclosure:
Dr. Pichardo receives grant/research support from Johnson and Johnson. 

Session date: 
07/27/2022 - 3:30pm to 4:00pm EDT
Location: 
Zoom
United States
See map: Google Maps
Add to calendar: 
  • 0.50 AMA PRA Category 1 Credit™

    Boston University Chobanian & Avedisian School of Medicine designates this Live activity for a maximum of 0.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 0.50 Participation

Please login or register to take this course.